Derivative Actions and Corporate Governance in China

Asian Commercial, Financial and Economic Law and Policy series

Jingchen Zhao, Professor of Law, Nottingham Law School, Nottingham Trent University, UK

这本书探讨公司治理ance rules in China, and highlights the deficiencies in current company law, with the purpose of arguing for a more effective derivative action mechanism, for the benefit of shareholders and their companies.

‘This new monograph by Professor Jingchen Zhao casts a light upon the use of derivative actions in the law of shareholder protection in China. Zhao’s well written and superbly researched text examines in forensic detail this relatively new feature of Company Law in China. It sets the scene by offering valuable insights into the Corporate Law and Governance context in China. The text reflects expertly upon the Chinese position after some 14 years of experience of derivative actions in that jurisdiction. It is a monograph that should be read by all scholars of comparative Company Law. Practitioners with links to and interest in shareholder protection law in China will find it a valuable vademecum.’
– David Milman, Lancaster University, UK

‘This fascinating new book by Professor Jingchen Zhao provides a distinctive, ambitious, and eminently rigorous study of derivative actions and corporate governance in China. The treatment of the subject area is significant, original, and a compelling read. Insightful and timely, it is a must-read for academic company lawyers across the world and should be on the reading list for any company law practitioners, fund managers, and entrepreneurs, and any postgraduate course on company law.’
– Wangwei Lin, University of Reading, UK

‘Derivative actions are potentially powerful weapons; much has been written about them but there has not been a really comprehensive study of them in China, and yet they are prospectively of great importance. In this work, and employing several pertinent research methods, Professor Zhao engages in a very extensive critical analysis of derivative actions in China and in the broader context of corporate governance that is most admirable and robust. Furthermore the study is very impressively sourced and clearly written.’
– Andrew Keay, University of Leeds, UK

2022 c 208 pp Hardback 978 1 78471 910 4 £80.00£72.00 $115.00$103.50

Elgaronline 978 1 78471 911 1

Edward Elgar Publishing Ltd. is registered in the UK at: The Lypiatts, 15 Lansdown Road,
Cheltenham, Glos GL50 2JA. Registered number: 2041703

How To Order

Online

m.ingmedical.com

Get up to 20% discount when you order online

By Email

UK/ROW:[email protected]

N/S America:[email protected]

By Phone

UK/ROW:+44 (0) 1243 843291

N/S America:(800) 390 - 3149

Connect With Us

Find us on Facebook

facebook.com/EdwardElgarPublishing

Follow us on Twitter

For news, views and offers

@ElgarPublishing

Read our Blog

For news, views and debate from our authors and readers.

https://www.elgar.blog

For More Information

UK/ROW:[email protected]

N/S America:[email protected]